NCT06106490View on ClinicalTrials.gov

Pain Managment in Chronic Shoulder Pain

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

November 30, 2024

Conditions
Chronic Pain Management
Interventions
OTHER

the effect of adding pulsed radiofrequency (PRF) modality to suprascapular nerve injection with ultrasound glenohumeral steroid in chronic shoulder pain patients

"Suprascapular nerve block group: Patients will receive ultrasound guided intra articular Gleno-humeral steroid injection of Diprofos® (betamethasone 14 mg/ 2ml) and ultrasound guided suprascapular nerve block US SSN with 10mL of 0.25% preservative-free bupivacaine~Pulsed radiofrequency group: Patients will receive ultrasound guided intra articular Gleno-humeral steroid injection of Diprofos® (betamethasone 14 mg/ 2ml) and ultrasound guided suprascapular nerve block US SSN with 10mL of 0.25% preservative-free bupivacaine with application of pulse PRF at 42 Celsius of suprascapular nerve for 480 seconds."

Trial Locations (1)

11566

RECRUITING

Faculty of medicine Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER